Concepedia

PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients

Federica Perrone, Andrea Lampis, Marta Orsenigo, Maria Di Bartolomeo, Arpine Gevorgyan, Marco Losa, Milo Frattini, Catherine Riva, Salvatore Andreola, Emilio Bajetta,

Annals of Oncology · 2008 · 414 citations · 27 references

DOIFull text

Open access

Concepts

References

27

Mutations of the BRAF gene in human cancer

Helen Davies, Graham R. Bignell, Charles Cox et al. · Nature · 2002 · 10.7K citations

, , +12

Wild-Type <i>KRAS</i> Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

Rafael G. Amado, Michael Wolf, Marc Peeters et al. · Journal of Clinical Oncology · 2008 · 3.2K citations · Full text

, , +17

<i>KRAS</i> Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer

Astrid Lièvre, Jean‐Baptiste Bachet, Delphine Le Corre et al. · Cancer Research · 2006 · 2.2K citations

, , +17

Cetuximab for the Treatment of Colorectal Cancer

Derek J. Jonker, Chris J. O’Callaghan, Christos S. Karapetis et al. · New England Journal of Medicine · 2007 · 1.8K citations · Full text

, , +17

Cetuximab in the treatment of colorectal cancer.

Richard M. Goldberg, Alan P. Venook, Richard L. Schilsky · PubMed · 2004 · 1.5K citations

, , +10